Navigation Links
Reportlinker Adds Biologic Imaging Reagents: Technologies and Global Markets Report
Date:9/3/2009

TABLE 86 GLOBAL VALUE OF OPTICAL FLUORESCENT IMAGING

REAGENTS, BY END USE, THROUGH 2013 ($ MILLIONS)

TABLE 87 GLOBAL VALUE OF IN-VITRO DIAGNOSTIC FLUORESCENT

OPTICAL IMAGING REAGENTS, BY MARKET SEGMENT, THROUGH

2013 ($ MILLIONS)

TABLE 88 GLOBAL VALUE OF OPTICAL IMAGING REAGENTS, BY

TYPE, THROUGH 2013 ($ MILLIONS)

TABLE 89 GLOBAL VALUE OF BIOLOGIC IMAGING REAGENTS, BY

GEOGRAPHY, THROUGH 2013 ($ MILLIONS)

TABLE 90 NUMBER OF PATENTS BY TECHNOLOGY

TABLE 91 FLUORESCENCE REAGENTS PATENT ASSIGNEES BY

COMPANY (NUMBER OF PATENTS)

TABLE 92 FLUORESCENT PROTEIN PATENT ASSIGNEES BY

COMPANY (NUMBER OF PATENTS)

TABLE 93 DENDRIMER PATENT ASSIGNEES BY COMPANY (NUMBER

OF PATENTS)

TABLE 94 QUANTUM DOTS PATENT ASSIGNEES BY COMPANY

(NUMBER OF PATENTS)

TABLE 95 IP LITIGATION STATUS

TABLE 96 ACUSPHERE PRODUCT PIPELINE

TABLE 97 ACUSPHERE PATENT ESTATE

TABLE 98 AMAG MOLECULAR IMAGING REAGENTS PIPELINE

TABLE 99 AMAG MRI IMAGING REAGENTS MARKETING ALLIANCES

TABLE 100 AVID DIAGNOSTIC IMAGING PIPELINE

TABLE 101 FLUORPHARMA PET IMAGING REAGENT PIPELINE

TABLE 102 GE HEALTHCARE IMAGING REAGENTS PIPELINE

TABLE 103 JUBILANT ORGANOSYS MEDICAL IMAGING REAGENT

PIPELINE

TABLE 104 KEREOS IMAGING REAGENTS PIPELINE

TABLE 105 KEREOS STRATEGIC ALLIANCES

TABLE 106 LANTHEUS DIAGNOSTIC IMAGING PIPELINE

TABLE 107 MTTI IMAGING REAGENTS PIPELINE

TABLE 108 NANOSPHERE GOLD IMAGING REAGENTS PIPELINE

TABLE 109 WILEX PRODUCT PIPELINE

LIST OF FIGURES

SUMMARY FIGURE GLOBAL VALUE OF BIOLOGIC IMAGING

REAGENTS, BY TYPE, 2006-2013 ($ MILLIONS)

FIGURE 1 MOLECULAR ENGINEERING OF DENDRIMER IMAGING

SUPERMOLECULES

FIGURE 2 QUANTUM DOT SPECTRA

FIGURE 3 FLUORESCENT DYE SPEC
'/>"/>

SOURCE Reportlinker
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine news :

1. Biologic treatment for rheumatoid arthritis and the risk of cancer
2. Thomson Scientific Announces BONDplus for Biological Researchers
3. Neurobiological Technologies Reports Going Concern Qualification
4. Neurobiological Technologies, Inc. Announces Receipt of Determination Letter from NASDAQ
5. Promising Phase 3 trial results show biologic therapy ustekinumab significantly improved psoriasis
6. Study questions assumptions about human sensitivity to biological motion
7. Neurobiological Technologies Reports $2.1 Million Quarterly Payment for Sales of Memantine
8. Neurobiological Technologies Announces Compliance With Nasdaq Listing Standards
9. Cell Therapeutics, Inc. (CTI) Plans to Submit Supplemental Biologics License Application (sBLA) for ZEVALIN(R) Consolidation of First Remission in Advanced Stage Follicular Lymphoma in 2008
10. Dr. Warren Wasiewski Appointed Chief Medical Officer of Neurobiological Technologies, Inc.
11. CalbaTech Reports That LifeStems Biologics License Has Been Renewed
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... ... ... Dignity Health named Dr. Norris A. Baldwin, Jr. the Facility Medical Director ... August. The new facility is licensed under Dignity Health Arizona General Hospital ... is an excellent leader and will ensure our new freestanding emergency room delivers the ...
(Date:8/3/2015)... ... August 03, 2015 , ... Hub International Insurance ... Williams has joined its growing California employee benefits division. Mr. Williams will ... his clients. Mr. Williams will be joining the newly integrated Northern California employee ...
(Date:8/3/2015)... ... August 03, 2015 , ... Constantin Vasilica, 48 from ... tissue injury caused by diabetes after many years of suffering and using medications with ... he didn’t want to ask for extra time off or wait longer hours in ...
(Date:8/3/2015)... ... August 03, 2015 , ... Cambia Health Solutions has promoted ... the company’s Medicare and Federal Employee Programs (FEP) lines of business. , ... for members. In this role, Scott is responsible for overseeing the growth, finance ...
(Date:8/3/2015)... ... 03, 2015 , ... Foot and Ankle Specialists of the Mid-Atlantic (FASMA) ... largest medical practice in the Mid-Atlantic region – and the second largest in the ... 33 doctors. , Dr. Hetal Kathrotiya-Mago is a Maryland native. She grew up in ...
Breaking Medicine News(10 mins):Health News:Dignity Health Names Dr. Norris A. Baldwin, Jr. Facility Medical Director of New Freestanding Emergency Room 2Health News:Dignity Health Names Dr. Norris A. Baldwin, Jr. Facility Medical Director of New Freestanding Emergency Room 3Health News:HUB International Insurance Services Announces Joe Williams Has Joined its Northern California Employee Benefits Division 2Health News:Chinese Health Care Provider Heshoutang Now Give Patients Complimentary Online Healing Options 2Health News:Chinese Health Care Provider Heshoutang Now Give Patients Complimentary Online Healing Options 3Health News:Cambia Health Solutions Names Scott Powers President of Government Programs 2Health News:Leading Foot and Ankle Medical Practice Adds Three New Podiatrists 2Health News:Leading Foot and Ankle Medical Practice Adds Three New Podiatrists 3Health News:Leading Foot and Ankle Medical Practice Adds Three New Podiatrists 4
... specialists from all over the world will meet at Mount ... heart disease in India and how preventive measures can help ... on Clinical & Preventive Cardiology is being held from September ... for several burning issues and newer technologies besides crystallizing recent ...
... recent clinical trials of inhaled insulin has received the approval ... in regulating blood sugar levels spanning a 2 year period. ... introduced into the United States market soon after the U.S. ... with Type 1 or Type 2 diabetes. ,Dr. Julio ...
... said that the breast cancer drug Herceptin was approved to be ... happy news to the grieving family of Tamar Bailey. //She is ... denied her the drug which led to her early death. She ... was an advertising art director from Wimbledon, south-west London. She had ...
... National Institute of Standards and Technology (NIST) researchers have ... of complex surfaces, which vary in a controlled fashion ... is so flexible that it can be applied to ... exploring the bonding of proteins to cell membranes. ...
... first spacewalk was successfully by two crewmen in the early ... jobs on the international space station within 6.5 hours on ... 8 hours and 56 minutes. Except for a video camera ... placed on a transport platform. ,After Russians have ...
... - high school and college students are now co-authors in ... of 30 macrophages has been made possible by digging in ... 9, 2006 has a report of a research team lead ... The report is about the characterization and cataloguing of genomes ...
Cached Medicine News:Health News:World Cong On Preventive Cardiology In Sept 2Health News:New Technique For Science Experiments 2
(Date:8/2/2015)... CARLSBAD, Calif. , Aug. 3, 2015 /PRNewswire/ ... AstraZeneca today announced a strategic collaboration to discover ... renal diseases. The new collaboration builds on a ... supports AstraZeneca,s strategic approach in these therapeutic areas ... Pharmaceuticals to extend use of its antisense technology ...
(Date:8/2/2015)... , August 3, 2015 Mandatory ... Dechra Pharmaceuticals PLC ("Dechra" or the "Company") is pleased ... agreement ("SPA") with Mr. Marijan Han žeković to ... in Genera d.d. ("Genera"), a Croatian listed pharmaceutical business. ... share, which is equivalent to €51.4 million for the ...
(Date:8/2/2015)... , Aug. 3, 2015  Lexicon Pharmaceuticals, Inc. ... pivotal TELESTAR Phase 3 clinical trial met its ... etiprate in treating cancer patients with carcinoid syndrome ... standard of care. Telotristat etiprate was discovered using ... and is the company,s first discovery to complete ...
Breaking Medicine Technology:AstraZeneca and Isis Pharmaceuticals to Discover and Develop Antisense Drugs for Cardiovascular, Metabolic and Renal Diseases 2AstraZeneca and Isis Pharmaceuticals to Discover and Develop Antisense Drugs for Cardiovascular, Metabolic and Renal Diseases 3AstraZeneca and Isis Pharmaceuticals to Discover and Develop Antisense Drugs for Cardiovascular, Metabolic and Renal Diseases 4Dechra to Acquire 63.3% Shareholding (£19.4m) in Genera d.d. Croatia 2Dechra to Acquire 63.3% Shareholding (£19.4m) in Genera d.d. Croatia 3Dechra to Acquire 63.3% Shareholding (£19.4m) in Genera d.d. Croatia 4Dechra to Acquire 63.3% Shareholding (£19.4m) in Genera d.d. Croatia 5Lexicon Pharmaceuticals Reports Positive Top-Line Results For Pivotal Phase 3 Telotristat Etiprate Study In Cancer Patients With Carcinoid Syndrome 2Lexicon Pharmaceuticals Reports Positive Top-Line Results For Pivotal Phase 3 Telotristat Etiprate Study In Cancer Patients With Carcinoid Syndrome 3Lexicon Pharmaceuticals Reports Positive Top-Line Results For Pivotal Phase 3 Telotristat Etiprate Study In Cancer Patients With Carcinoid Syndrome 4Lexicon Pharmaceuticals Reports Positive Top-Line Results For Pivotal Phase 3 Telotristat Etiprate Study In Cancer Patients With Carcinoid Syndrome 5Lexicon Pharmaceuticals Reports Positive Top-Line Results For Pivotal Phase 3 Telotristat Etiprate Study In Cancer Patients With Carcinoid Syndrome 6
...  With increasing demands for time spreading consumers thin — ... to and from their many appointments — running errands ... simpler for shoppers always on the go, Shopko announces ... to quickly and easily refill and manage their pharmacy ...
... SAN FRANCISCO, Jan. 10, 2012  The University of California, San ... Sanofi (EURONEXT: SAN and NYSE: SNY ) to ... could lead to new therapies for both type 1 and ... will bring together scientists in three UCSF labs with deep ...
Cached Medicine Technology:Shopko Launches Mobile Pharmacy App to Maximize Customer Convenience 2UCSF, Sanofi Collaborate to Find New Diabetes Cures 2UCSF, Sanofi Collaborate to Find New Diabetes Cures 3UCSF, Sanofi Collaborate to Find New Diabetes Cures 4UCSF, Sanofi Collaborate to Find New Diabetes Cures 5
... This stool is unquestionably the finest operating room ... for the ophthalmic surgeon who must remain ... poor stool can unexpectedly shift resulting in unanticipated ... base of five sturdy casters. A "foot bar" ...
... The Multi-Cap system provides patients ... from distance viewing to reading. ... 1.75x for distance viewing. The ... 2x, 3x and 4x magnifications. ...
... The Wide-Vu magnifier is ... telescope for reading. It ... view than the LVA21 and ... distance. The Wide-Vu can be ...
... takes us to the practical limit ... is often a 'last resort' option ... acuities. The illuminated housing ensures a ... the battery handle by a lightweight ...
Medicine Products: